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Gammaherpesviruses infect at least 90% of the world’s population. Infection control is difficult, in
part because some fundamental features of host colonization remain unknown, for example
whether normal latency establishment requires viral lytic functions. Since human
gammaherpesviruses have narrow species tropisms, answering such questions requires animal
models. Murid herpesvirus-4 (MuHV-4) provides one of the most tractable. MuHV-4 genomes
delivered to the lung or peritoneum persist without lytic replication. However, they fail to
disseminate systemically, suggesting that the outcome is inoculation route-dependent. After
upper respiratory tract inoculation, MuHV-4 infects mice without involving the lungs or
peritoneum. We examined whether host entry by this less invasive route requires the viral
thymidine kinase (TK), a gene classically essential for lytic replication in terminally differentiated
cells. MuHV-4 TK knockouts delivered to the lung or peritoneum were attenuated but still reached
lymphoid tissue. In contrast, TK knockouts delivered to the upper respiratory tract largely failed to
establish a detectable infection. Therefore TK, and by implication lytic replication, is required for
MuHV-4 to establish a significant infection by a non-invasive route.
INTRODUCTION
Gammaherpesviruses persist in lymphocytes and use
lymphocyte proliferation to amplify their latent genome
loads. Viral immune evasion (Stevenson, 2004) makes this
process hard to stop. It also makes long-term infection
hard to clear. The initial establishment of lymphocyte
infection by virions entering a naive host is therefore a key
target for infection control.
Gammaherpesviruses, like many other mammalian herpes-
viruses, are thought to be transmitted via saliva (Yao et al.,
1985). Epstein–Barr virus (EBV), as the most intensively
studied example, provides something of an archetype. It
infects epithelial cells poorly in vitro, and has therefore
been proposed to infect in vivo by saliva reaching B cells in
tonsillar crypts (Faulkner et al., 2000; Thorley-Lawson,
2001), where infection is abundant during infectious
mononucleosis. However, infectious mononucleosis occurs
at least 1 month after actual transmission (Hoagland,
1964). Therefore, tonsillar infection could just as easily
represent EBV exit. One prediction of the direct B cell
infection hypothesis, that antibodies to gp350, which block
B cell infection in vitro (Thorley-Lawson & Geilinger,
1980), would reduce host entry in vivo, was not fulfilled
(Sokal et al., 2007). Blocking gp350-independent (non-B
cell) EBV infection (Janz et al., 2000) would require a
different vaccine. Therefore it is important for infection
control to understand how gammaherpesviruses enter their
hosts.
Both EBV and the other known human gammaherpesvirus,
the Kaposi’s sarcoma-associated herpesvirus (KSHV), are
difficult to study in vivo. Therefore the small animal model
provided by murid herpesvirus-4 (MuHV-4) (Nash et al.,
2001; Stevenson & Efstathiou, 2005) provides a useful
means of analysing gammaherpesvirus pathogenesis.
MuHV-4 is more closely related to KSHV than to EBV,
but epithelial and B cell tropisms are common to all three
viruses, and presumably pre-date their divergence; similar
routes of host colonization are therefore likely. The main
natural host of MuHV-4 appears to be yellow-necked mice
(Apodemus flavicollis) (Kozuch et al., 1993). However, it
behaves like a natural parasite also in Mus musculus-
derived laboratory strains, persisting without disease unless
there is immunosuppression (Virgin & Speck, 1999).
Moreover its immune-evasion genes, typically the most
host-restricted of viral functions, seem to work normally in
laboratory mice, even showing strain specificity (Boname
et al., 2004). MuHV-4 infection of laboratory mice
therefore seems to offer a reasonable physiological model
of gammaherpesvirus infection. 3Present address: CSL Limited, Melbourne, Australia.
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general anaesthesia and a large inoculum volume are used
to deliver virions directly to the lung alveoli, where lytic
replication occurs. Vaccination against viral lytic antigens
largely blocks this replication, but does not block latency
establishment (Stevenson et al., 1999). Thymidine kinase
(TK)-deficient mutants show a severe lytic replication
defect in lungs, but still establish normal long-term latency
in spleens (Coleman et al., 2003). The establishment of B-
cell latency after lung infection is therefore independent of
the extent of viral lytic replication. Completely replication-
deficient MuHV-4 genomes can also persist after delivery
to the lung alveoli or the peritoneal cavity. Thus, ORF6
2
MuHV-4 infects peritoneal macrophages, but not splenic B
cells after intraperitoneal inoculation (Tibbetts et al., 2006);
ORF31
2 MuHV-4 reaches the spleen after intraperitoneal
inoculation, but not after lung inoculation (Kayhan et al.,
2007); and ORF50
2 MuHV-4 colonizes B cells in the lung,
but not in the spleen, after lung inoculation (Moser et al.,
2006). This last result is hard to understand, because B cells
infected in the lung should recirculate to the spleen, and it
is possible that some of the PCR-based assays of host
colonization used with replication-deficient mutants
detected input viral debris rather than bona fide infected
cells. The conservative conclusion would be that systemic
lymphoid tissue is not readily accessible to MuHV-4
delivered by the intranasal route. Nevertheless, all these
studies concluded that replication-deficient viruses estab-
lished significant persistent infections.
The value of an animal model depends not just on
sophisticated genetic techniques, but on ecological con-
siderations such as how virions might normally enter their
hosts. Intranasal virus inoculation is more likely than
intraperitoneal inoculation to reflect natural infection.
However, direct virus delivery to the lung may also be
misleading. MuHV-4 given intranasally in low volumes
without anaesthesia replicates lytically just in the nose
(Milho et al., 2009). A persistent, systemic infection is
nevertheless robustly established even with low-dose
inoculations. In contrast, orally delivered virus is very
poorly infectious (Milho et al., 2009). Therefore the nose,
but not the lung, is a plausible natural portal of host entry.
Distinguishing upper and lower respiratory tract entry
routes is important, as they involve very different epithelial
surfaces. In order to explore further the requirements of
MuHV-4 for host colonization via the upper respiratory
tract, we infected mice with TK-deficient mutants
(Coleman et al., 2003). We used these in preference to
completely replication-deficient mutants for two reasons:
first, we are interested in viral functions that are specifically
required for replication in vivo, and TK
2 MuHV-4
replicates normally in vitro; second, the normal in vitro
replication of TK
2 mutants places less reliance on
measuring host colonization by viral DNA loads, which
do not distinguish viable genomes from non-infectious
debris. In contrast to lung or peritoneal infections, TK
2
virions delivered to the upper respiratory tract failed to
establish a detectable infection. The herpes simplex virus
(HSV) TK is largely redundant for epithelial infection, but
is essential for lytic replication in terminally differentiated
neurons (Efstathiou et al., 1989; Coen et al., 1989; Valyi-
Nagy et al., 1994). Therefore, MuHV-4 may have to pass
through terminally differentiated cells when infecting via
the nose, suggesting that TK-based therapies have the
potential to block gammaherpesvirus spread.
METHODS
Mice. Female BALB/c mice were infected with MuHV-4 when 6–
12 weeks old. Intranasal infections were either in 30 ml under deep
general anaesthesia (lower respiratory tract infection) or in 5 ml under
light anaesthesia (upper respiratory tract infection). Intraperitoneal
infections were in 300 ml. For luciferase imaging, mice were given
intraperitoneal injections of luciferin (2 mg per mouse), anaesthe-
tized with isoflurane, then scanned with an IVIS Lumina (Caliper Life
Sciences). Quantitative comparisons used the maximum radiance
(photons s
21 cm
22 steradian
21) over each region of interest, relative
to a negative control region. All experiments conformed to local
animal ethics regulations and Home Office Project Licence 80/1992.
Cells. BHK-21, 293T, NIH-3T3-CRE (Stevenson et al., 2002) and
RAW-264 cells were propagated in Dulbecco’s modified Eagle’s
medium (Invitrogen), supplemented with 2 mM glutamine, 100 U
penicillin ml
21, 100 mg streptomycin ml
21 and 10% fetal calf serum.
Peritoneal cells were obtained by a post-mortem injection and
aspiration of 10 ml PBS. Typically 50% of the cells recovered were
macrophages (CD19
2F4/80
+ by flow cytometry). The remainder
were B cells (CD19
+F4/80
2). Selection by adherence to plastic
increased the proportion of macrophages to .90%.
Viruses. The TK
2KAN
2 mutant, its revertant, and the TK
2DEL
mutant have been described previously (Coleman et al., 2003). We
generated LUC
+ TK knockouts by shuttling the M3-LUC reporter
construct (Milho et al., 2009) into the TK
2KAN
2 bacterial artificial
chromosome (BAC). We also combined the TK
2KAN
2 mutation
with enhanced GFP (eGFP)-tagged gM (Smith et al., 2007) and with
gp150 disruption (M7
2STOP) (de Lima et al., 2004). The integrity of
each recombinant BAC was confirmed by restriction endonuclease
mapping. Infectious virions were recovered by transfecting BAC DNA
into BHK-21 cells. For in vivo experiments, the loxP-flanked viral
BAC/eGFP cassette was removed by passage through NIH-3T3-CRE
cells. Virus stocks were grown in BHK-21 cells (de Lima et al., 2004).
Infectivity assays. Virus stocks were titrated by plaque assay on
BHK-21 cells (de Lima et al., 2004): cell monolayers were incubated
with virus (2 h, 37 uC), overlaid with 0.3% carboxymethylcellulose,
and 4 days later fixed and stained for plaque counting. Infectious
virus in ex vivo tissues was measured by plaque assay of freeze–thawed
tissue homogenates. To titre noses, we removed a block of tissue
bounded by (i.e. not including) anteriorly the cartilaginous tip of the
nose, posteriorly the orbits, laterally the zygomatic arches, ventrally
the palate and dorsally the nasal bones. This region contained all the
luciferase signal measureable by ex vivo charge-coupled device (CCD)
camera scanning. Bone fragments were discarded after homogeniza-
tion. The latent virus in ex vivo tissues was measured by infectious
centre assay (de Lima et al., 2004): spleen or superficial cervical lymph
node (SCLN) suspensions were co-cultured with BHK-21 cells, then
fixed and stained for plaque counting after 4 days. Pre-formed
infectious virus titres in lymphoid tissue, as measured by plaque assay
of freeze–thawed cells, were always ,1% of infectious centre assay
titres.
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real-time PCR (Gaspar et al., 2008). DNA (50–80 ng) was extracted
from ex vivo organs (Wizard genomic DNA purification kit;
Promega) and used to amplify MuHV-4 genomic co-ordinates
4166–4252 (Rotor Gene 3000; Corbett Research). The PCR products
were quantified by hybridization with a Taqman probe (genomic
coordinates 4218–4189) and converted to genome copies by
comparison with a standard curve of cloned plasmid template,
amplified in parallel. Cellular DNA was quantified in parallel by
amplifying part of the adenosine phosphoribosyltransferase gene
(forward primer 59-GGGGCAAAACCAAAAAAGGA-39, reverse pri-
mer 59-TGTGTGTGGGGCCTGAGTC-39, probe 59-TGCCTAAACA-
CAAGCATCCCTACCTCAA-39).
ELISA. MuHV-4 virions were recovered from infected BHK-21 cell
supernatants by ultracentrifugation, disrupted with 0.05% Triton X-
100 in 50 mM sodium carbonate buffer (pH 8.5), and coated (18 h,
4 uC) onto Maxisorp ELISA plates (Nalgene Nunc). The plates were
washed three times in PBS/0.1% Tween-20, blocked with 2% BSA in
PBS/0.1% Tween-20 (1 h, 23 uC), then incubated with threefold
serum dilutions from MuHV-4-exposed mice (1 h, 23 uC). The plates
were then washed four times in PBS/0.1% Tween-20, incubated (1 h,
23 uC) with alkaline phosphatase-conjugated goat anti-mouse IgG-Fc
pAb (Sigma), washed five times, and developed with nitrophenylphos-
phate (Sigma). Absorbance was read at 405 nm (Bio-Rad Benchmark
ELISA plate reader).
RESULTS
Total respiratory tract infection by TK
” MuHV-4
MuHV-4 TK knockouts have a severe lytic replication
defect in lungs as measured by plaque assay (Coleman et al.,
2003). Viral luciferase expression provides an alternative
means of tracking infection that can be applied to live mice
(Milho et al., 2009). We expressed luciferase from an early
lytic MuHV-4 promoter, making it a subtly different
readout to plaque assays, which also require viral late
functions to form infectious virions. Since TK is thought to
function mainly in viral DNA replication, luciferase
expression should provide a more sensitive measure of
host colonization by TK
2 mutants. Like other TK knock-
outs (Coleman et al., 2003), luciferase
+TK
2 MuHV-4
replicated normally in vitro. Its TK status was confirmed by
staining infected cells with the TK-specific mAb CS-4A5
(May et al., 2008) (data not shown).
After intranasal virus inoculation (10
3 p.f.u.) under deep
anaesthesia (Fig. 1), luciferase expression was detectable in
the lungs of mice given either TK
+ or TK
2 viruses.
However, the TK
2 mutant showed no luciferase signal in
the nose (Fig. 1a, b). Therefore the TK-dependent
reduction in early lytic gene expression, presumably
reflecting reduced lytic spread, was greater in noses than
in lungs. Infectious TK
2 MuHV-4 was undetectable in
both noses and lungs by plaque assay (Fig. 1c).
Upper respiratory tract infection by TK
” MuHV-4
We explored the TK-dependent upper respiratory
tract infection defect further by low-volume intranasal
Fig. 1. Luciferase imaging of TK
” MuHV-4 infection in the lower
respiratory tract. (a) Mice were infected intranasally (10
3 p.f.u.,
30 ml) under general anaesthesia with TK
+ or TK
” luciferase
+
MuHV-4, then after 3 days received injections of luciferase and
were imaged by CCD camera scanning. The images show dorsal
and ventral views of three mice per group. The bar shows the
colour scheme of relative signal intensity. (b) Maximum luciferase
signal intensities in the noses and lungs of mice (six per group)
infected with TK
+ or TK
” luciferase
+ MuHV-4 were monitored as
in (a). Each point shows the signal of one mouse. The dashed lines
show lower limits of detectable signal intensity. (c) Plaque assays
of mouse noses and lungs, 7 days after infection with TK
+ or TK
”
luciferase
+ MuHV-4 as in (a). Each point shows the titre of one
mouse. The dashed lines show lower limits of assay sensitivity.
MuHV-4 host entry
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the nose, because none of the inoculum is aspirated into
the lung. Again there was no evidence of luciferase
expression in the nose by the TK knockout (Fig. 2a, b).
Nor was there a later signal in the neck (Fig. 2c), which
corresponds to viral latency establishment in the SCLN
(Milho et al., 2009). Therefore, TK
2 MuHV-4 appeared
not to establish a significant infection via the upper
respiratory tract.
TK
2 MuHV-4 delivered to the lung establishes latency
despite its lytic replication defect: reactivatable virus is
present in the spleen and antibodies to viral lytic antigens
are present in serum by 1 month post-inoculation
(Coleman et al., 2003). Given the minimal primary lytic
spread of TK
2 mutants, this antibody response presumably
reflects latency-associated lymphoproliferation, followed by
reactivation. At any rate, it provides a sensitive measure of
host colonization. TK
2 MuHV-4 delivered to the upper
respiratory tract had elicited no detectable antibody
response after 1 month (Fig. 3a). Infectious centres were
also undetectable in spleens or SCLN (Fig. 3b), and only
one mouse showed a viral genome PCR signal above
background levels (Fig. 3c). Even that signal was very low,
suggesting sample contamination or the detection of input
viral debris transported to draining lymph nodes. Splenic
PCR signals, which are probably a more stringent test of
significant host colonization, were all negative. Therefore,
TK
2 MuHV-4 seemed to infect mice poorly via the upper
respiratory tract.
We then tested our original, luciferase
2 TK knockouts
(TK
2KAN
2,T K
2DEL) for host colonization via the upper
respiratory tract (Fig. 4). We also increased the inoculation
dose to 10
4 p.f.u. so as to test maximally any resistance to
infection. This confirmed the finding with the luciferase
+
TK mutant: only two out of ten mice exposed to high dose
TK
2 MuHV-4 had detectable virus by infectious centre
assay of spleens (Fig. 4a), and only three out of ten had
detectable antibody responses (Fig. 4b), whereas all control
mice were infected. As 10 p.f.u. wild-type MuHV-4 readily
infects mice via the upper respiratory tract (Milho et al.,
2009), TK knockouts were at least 100-fold less capable of
establishing a detectable infection. Comparing different
doses of TK
+ and TK
2 viruses (Fig. 4c), and assaying
infection by ELISA of serum for MuHV-4-specific IgG at
1 month post-infection (the most sensitive measure),
showed TK
2 infection to be inefficient via either the
upper or the lower respiratory tract. Upper respiratory
tract TK
2 infection appeared to be less efficient, but the
difference between inoculation routes did not reach
statistical significance.
Peritoneal infection by TK
” MuHV-4
Several studies of host colonization by replication-deficient
MuHV-4 mutants have used intraperitoneal inoculation.
For the purpose of comparison, therefore, we also looked
at this route of infection with TK
2 mutants (Fig. 5). We
Fig. 2. TK
” MuHV-4 infection of the upper respiratory tract. (a)
Mice were inoculated intranasally with TK
+ or TK
” luciferase
+
MuHV-4 (10
3 p.f.u. in 5 ml), then imaged for luciferase expression
over the next 10 days. Each point shows the maximum radiance
signal of one mouse. The dashed line shows the lower limit of
assay sensitivity. (b) Example dorsal and ventral views of luciferase
signals 3 days after infection with 5 mlT K
+ or TK
” luciferase
+
MuHV-4. (c) Luciferase signals at 10 days after infection of four
mice each with 5 mlT K
+ or TK
” luciferase
+ MuHV-4. The neck
signal is from the superficial cervical lymph nodes.
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2KAN
2 virus by the standard
infectious centre assay of spleens and peritoneal macro-
phages (Fig. 5a). Some infectivity was recoverable from
spleens, although at least tenfold less than with TK
+
controls. No TK
2 infectivity was recovered from peritoneal
macrophages. Real-time PCR showed relatively normal
TK
2 viral genome loads in peritoneal cells and spleens (Fig.
5b). Therefore, the low plaque titres of the TK
2KAN
2
mutant appeared to reflect mainly poor infectious virion
production. Live imaging of infected cells (Fig. 5c, d)
supported this idea, with relatively little TK-dependent
deficit.
We defined the sources of luciferase signals by ex vivo
imaging of dissected organs (Fig. 6). TK
+ MuHV-4
showed widespread peritoneal infection, with luciferase
expression in intestines, spleen, reproductive tract, dia-
phragm, adrenals and pancreas (Fig. 6a). The apparent lack
of kidney, liver or spleen signals in Fig. 6(a) reflects only
that the image sensitivity was set low to keep the strong
reproductive tract signal on scale – none of these organs
was completely luciferase-negative. Intraperitoneal TK
2
luciferase signals were generally lower than wild-type, but
again no peritoneal organs were consistently luciferase-
negative. Therefore, the pattern was very different from
that for upper respiratory tract infection, where the noses
of mice given intranasal TK
2 MuHV-4 were always
luciferase-negative. The strongest and most consistent
intraperitoneal TK
2 luciferase signals, as with TK
+, were
those of the reproductive tract, omentum and diaphragm.
Fig. 6(b) shows quantitative comparisons of four to six
mice per group.
Infectious virus (TK
+ or TK
2) was hard to recover from
the omentum because the associated fat was toxic to BHK-
21 cells, and infectious virus was recovered only incon-
sistently from the diaphragm. The reproductive tract was
the most reliable source of both TK
+ and TK
2 infectious
virions. The spleen also yielded infectious TK
2 virions, as
before (Fig. 5a). Both organs showed substantially greater
TK-dependent virion production defects than luciferase
expression defects. The kidneys and adrenals were positive
only for TK
+ virions. Nevertheless, TK
2 mutants
remained infectious by the intraperitoneal route.
Macrophage infection by TK
” MuHV-4
Since peritoneal macrophages showed no sign of producing
infectious TK
2 virions, we used them to define further the
nature of the TK-dependent infection defect (Fig. 7).
Growth curves showed poor TK
2 virion production by
primary peritoneal macrophages, but not by the trans-
formed monocyte/macrophage cell line RAW-264 (Fig. 7a).
TK knockouts also failed to replicate in bone-marrow-
derived dendritic cells (data not shown). TK
2 virion entry
into peritoneal macrophages did not seem to be impaired,
as, for a given level of viral eGFP expression in 293T cells,
eGFP expression in peritoneal macrophages was similar
between TK
2 and TK
+ viruses (Fig. 7b). We have shown
previously that this viral eGFP expression is independent of
lytic replication (Smith et al., 2007).
Fig. 3. No late colonization of mice by TK
” MuHV-4 delivered to
the upper respiratory tract. (a) Mice were inoculated intranasally
(10
3 p.f.u., 5 ml) with TK
+ or TK
” luciferase
+ MuHV-4, then
analysed for MuHV-4-specific IgG at 1 month post-infection by
ELISA. Each line shows the result for one mouse. Pooled naive
sera provide the negative control. (b) The same mice as in (a) were
analysed for reactivatable splenic virus by infectious centre assay.
Each point shows the titre for one mouse. The dashed lines show
lower limits of assay sensitivity. (c) The same samples as in (b)
were analysed for viral genomes by real-time PCR of DNA from
spleens or SCLN. Each point shows the viral genome copy number
of one mouse, normalized by the host genome copy number of the
same sample (1000 viral genomes per host genome). The
dashed lines show lower limits of assay sensitivity.
MuHV-4 host entry
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ciently than it infects fibroblasts, presumably because
macrophages express only low levels of the heparan sulfate
that MuHV-4 requires for cell binding (Gillet et al., 2007).
Therefore, it was possible that a general inefficiency of entry
masked an additional TK-dependent defect. We addressed
this by disrupting the MuHV-4 M7 ORF, which encodes
gp150. gp150
2 virions are heparan sulfate-independent and
consequently infect macrophages as efficiently as they infect
fibroblasts (de Lima et al., 2004). Viral eGFP expression in
peritoneal macrophages on an M7
2 virus background
remained TK-independent (Fig. 7c).
Immune fluorescence of ex vivo peritoneal macrophage
infections (Fig. 7d) showed that TK
+ and TK
2 virions
were both endocytosed (cytoplasmic glycoprotein and
capsid staining), but that only TK
+ virions gave new late
lytic gene expression (nuclear capsid staining). This result
was consistent with TK
2 MuHV-4 infecting but then
failing to replicate in peritoneal macrophages in vivo
(Fig. 5). Therefore, the TK-dependent macrophage infec-
tion defect matched the pattern expected for a virus not
producing enough phosphorylated thymidine to replicate
in terminally differentiated cells.
DISCUSSION
Our aim in analysing gammaherpesvirus host entry has
been to reveal new targets for infection control. We showed
here that MuHV-4 requires its TK to establish a significant
infection of mice via the upper respiratory tract. More
invasive infections were less TK-dependent, but they are
less physiological. HSV requires its TK to replicate in
terminally differentiated neurons. Gammaherpesvirus TKs
are not necessarily the same, but TK
2 MuHV-4 showed a
macrophage infection defect consistent with impaired viral
DNA replication in terminally differentiated cells. A similar
Fig. 4. Analysis of infection by luciferase
” TK mutants. (a) Mice
were inoculated intranasally (10
4 p.f.u., 5 ml) with TK
+ (wild-type
or revertant) or TK
” viruses (TK
”KAN
”,T K
”DEL). One month later
spleens were assayed for replication-competent virus by infectious
centre assay. (b) Sera from the same mice were assayed for
MuHV-4-specific IgG by ELISA. Sera from three age-matched
naive mice were assayed in parallel. Each line shows the result for
one mouse. (c) Mice were inoculated intranasally (10
3 p.f.u.) with
TK
+ or TK
” MuHV-4 in 30 ml (lung infection) or 5 ml (nose
infection), and 1 month later assayed for MuHV-4-specific serum
IgG as in (b). Each mouse was scored as infected or not
depending on whether the absorbance value with a 1:100 serum
dilution exceeded that of age-matched naive controls. Each bar
shows the percentage positive of 6–10 mice per group. Except for
the 1 p.f.u. nose and 100 p.f.u. lung infections, all TK
” infection
rates were significantly less than those for TK
+ (P,0.02 by
Fisher’s exact test).
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pesviruses would make their lytic genes potential targets for
infection control.
The phenotype of TK
2 MuHV-4 raised some general
questions about gammaherpesvirus host entry. We assume
that TK
2 virions still infected cells in the upper respiratory
tract, but that the number of cells supporting early lytic
gene expression was insufficient for a detectable luciferase
signal and without TK, infection did not spread. This
would make B cells an unlikely primary target for incoming
virions, as TK
2 mutants can both replicate in B cells and
drive their proliferation (Coleman et al., 2003). The poor
in vitro binding of cell-free MuHV-4 virions to B cells
(Gillet & Stevenson, 2007) would also argue against direct
infection in vivo. The poor replication of TK
2 MuHV-4 in
macrophages could explain TK-dependent host entry if
macrophages were a significant primary target. However,
cell-free virions also infect macrophages rather poorly
(Rosa et al., 2007), and it is unclear what proportion of
nasal antigens are sampled by macrophages or dendritic
cells. Macrophages are a more plausible primary target in
lung alveoli and in the peritoneal cavity, where they have
an important scavenging function, but infection in these
sites must be considered atypical.
Epithelial cells remain a plausible primary target. However,
any epithelial entry model must explain how MuHV-4
virions, which are highly heparan sulfate-dependent in
vitro, cope with epithelial heparan sulfate being predomi-
nantly basolateral in vivo (Hayashi et al., 1987). The failure
of wild-type MuHV-4 to infect mice orally (Milho et al.,
Fig. 5. Intraperitoneal infection by TK
” MuHV-
4. (a) Mice were infected intraperitoneally
(10
3 p.f.u.) with TK
+ (WT, REV) or TK
”
(TK
”KAN
”) MuHV-4. Macrophages were then
recovered by peritoneal lavage, and these and
spleen cells were titrated for recoverable virus
by infectious centre assay. Dashed lines show
the lower limits of assay sensitivity. Each point
shows the titre for one mouse. (b) Viral
genome loads in DNA from the peritoneal
and spleen cell samples in (a) were quantified
by real-time PCR. Each point shows the value
for one mouse, normalized by the host genome
copy number of the same sample. The dashed
line shows the lower limit of signal detection.
(c) Mice were infected intraperitoneally
(10
3 p.f.u.) with TK
+ or TK
” luciferase
+
MuHV-4, and 2 days later imaged by luciferin
injection and CCD camera scanning. The
colour scheme of relative signal intensity is as
for Figs 1 and 2. (d) Maximum radiance values
after TK
” and TK
+ intraperitoneal virus inocu-
lations were calculated from scanned images
using Living Image software. Each point shows
the value for one mouse. The dashed line
shows the lower limit of signal detection.
MuHV-4 host entry
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Therefore epithelial entry is far from certain. One possibility
suggested by the phenotype of TK
2 HSV (Efstathiou et al.,
1989; Coen et al., 1989; Valyi-Nagy et al., 1994) is that
incoming MuHV-4 infects olfactory neurons. These display
heparan sulfate on syndecan-3 (Raulo et al., 1994) and
engage in environmental sampling. However, TK might be
also required simply because the accessible epithelial cells are
terminallydifferentiated.WhileTK
2HSVshowsonly amild
epithelial replication defect, experimental HSV infection
involves deliberate scarification that would stimulate local
cell division; the normal state of most cells is quiescence.
Notably, we recovered infectious TK
2 virions from only the
reproductive tract and spleen, where mitotic rates are
relatively high. Therefore further analysis is required to
identify precisely where in the upper respiratory tract host
colonization by TK
2 virions fails.
Whatever cell type MuHV-4 first targets, nasal host entry
makes sense in its seclusion from any salivary route of virion
exit. All viruses, being non-motile, must somehow combine
efficient capture for host entry with efficient release for exit.
Unlike the gut, the respiratory tract presents an anatomical
dead end, necessitating bidirectional traffic. Epidemic
respiratory viruses manage this by replicating to high titre,
causing epithelial destruction, and stimulating sneezing and
coughing. Herpesviruses, in contrast, rely on the chronic,
asymptomatic shedding of low virion numbers. MuHV-4-
infected cells show reduced heparan sulfate expression (de
Lima et al., 2004) and secrete gp70 to block local heparan
sulfate rebinding (Gillet et al., 2007), but these mechanisms
are unlikely to operate beyond the millimetre (100-cell
diameter) scale; host exit means travelling centimetres.
Alphaherpesviruses have contrived cutaneous exit routes
that are anatomically distinct from mucosal entry. Nasal
entry and salivary exit could achieve the same for
gammaherpesviruses. Such a scheme is perhaps less obvious
for EBV and KSHV, because human noses are used less than
those of rodents, but it begs to be explored.
Fig. 6. Intraperitoneal infection by TK
” MuHV-
4: individual organs. (a) Mice were infected
intraperitoneally with TK
+ or TK
” luciferase
+
MuHV-4 (10
3 p.f.u.), and 5 days later imaged
for luciferase expression, first live and then
post-mortem after dissection. Representative
examples are shown. (b) Quantification of data
equivalent to those of (a), showing maximum
radiance values for the omentum, reproductive
tract and diaphragm of six mice per group.
Each point shows the signal for one mouse.
The dashed lines show signal detection limits.
(c) Virus titres of samples from equivalent
infections to (b), measured by plaque assay.
Each point shows the titre for one mouse. The
dashed lines show lower limits of detection.
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